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Glycosphingolipids (GSLs) are ubiquitous membrane components and have key roles in
biological systems, acting as second messengers or modulators of signal transduction
by affecting several events, ranging from cell adhesion, cell growth, cell motility,
regulation of apoptosis and cell cycle. Over the last 20 years our laboratory and
other research groups determined the glycan and ceramide structures of more than
20 GSLs from several pathogenic/opportunistic fungi, using a combination of gas
chromatography, mass spectrometry, nuclear magnetic resonance as well as other
immunochemical and biochemical techniques. Fungal GSLs can be divided in two major
classes: neutral GSLs, galactosyl- and glucosylceramide (GlcCer), and acidic GSLs,
the glycosylinositol-phosphorylceramides (GIPCs). Glycosyl structures in fungal GIPCs
exhibited significant structural diversity and distinct composition when compared to
mammalian GSLs, e.g., the expression of inositol-mannose and inositol-glucosamine cores
and the terminal residue of β-D-galactofuranose which are absent in mammalian cells.
Studies performed by our group demonstrated that GIPC (Galfβ6[Manα3]Manα2InsPCer)
elicited in patients with paracoccidioidomycosis an immune response with production
of antibodies directed to the terminal residue of β-D-galactofuranose. Further studies
also showed that inhibition of GlcCer biosynthetic pathways affects fungal colony
formation, spore germination and hyphal growth, indicating that enzymes involved in
GlcCer biosynthesis may represent promising targets for the therapy of fungal infections.
Recently, it was shown that GlcCer and GIPCs are preferentially localized in membrane
microdomains and monoclonal antibodies directed to these GSLs interfere in several
fungal biological processes such as growth and morphological transition. This review
focuses on glycan structures carried on sphingolipids of pathogenic/opportunistic fungi,
and aspects of their biological significance are discussed.
Keywords: fungal glycosphingolipids, glucosylceramide, glycosylinositol phosphorylceramides, glycosphingolipid
synthesis inhibitors, fungal membrane microdomains
INTRODUCTION
Glycosphingolipids (GSLs) are ubiquitous membrane compo-
nents present mostly in the outer leaflet of the plasma membrane
with their carbohydrate head groups exposed to the extracellular
space, andmainly organized inmicrodomains by association with
sterols and specific proteins.
The glycosphingolipid biosynthesis starts by the action of
serine palmitoyltransferase which condensates palmitoyl-CoA
with serine forming 3-keto-sphinganine, the keto group is
reduced to hydroxyl group thus forming the dihydrosphingosine
(also termed sphinganine), at this point, as shown in Figure 1,
the dihydrosphingosine may be hydroxylated on the C4 to form
the phytosphingosine (4-hydroxysphinganine). Specific acyl
transferases act upon dihydrosphingosine and phytosphingosine
forming dihydroceramide or phytoceramide, respectively. In
dihydroceramides, a desaturase inserts a double bound at C4
converting it in ceramide (Rhome et al., 2007). In fungi Glc
or Gal residues are transferred to ceramide in the assembly of
GlcCer or GalCer whereas the more complex glycan moieties of
GIPCs are built up on phytoceramide (Takahashi et al., 2009).
After glycosylation, GSLs are transported to the outer leaflet of
the cell membrane forming membrane microdomains, also as
described by Longo et al. (2013), GlcCer may also be found in
lipid vesicles in the cell wall, probably being part of the exocytosis
transport system.
Studies analyzing the roles of glycosphingolipids (GSLs) in
different biological systems have demonstrated their associa-
tion with: (i) oncogenic transformation; (ii) embryonic devel-
opment; (iii) control of cell division; (iv) cell adhesion and
motility; (v) signal transduction pathways by glycosinapses, e.g.,
carbohydrate-carbohydrate interactions; and (vi) control of cell
phenotype (Hakomori, 2004, 2008). Since the first description of
GSLs in fungi (Steiner et al., 1969), numerous studies focused in
structural elucidation and biological significance of these GSLs
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FIGURE 1 | Fungal and mammal GSLs biosynthetic pathways and
potential targets for new antifungal therapies. The scheme displays the
biosynthetic pathways of fungal GIPCs (left), fungal GlcCer (center), and
mammalian GSLs (right). The red arrows indicates the biosynthetic step
where the inhibition by AbA and P4/analogs occurs, the red dashed boxes in
the glycosphingolipid biosynthetic pathway indicate potential targets for the
development of new antifungal therapies. LCB, long chain base; FA, fatty
acid; IPC, inositol phosphorylceramide; MIPC, mannosylinositol
phosphorylceramide; GIPC, glycosylinositol phosphorylceramide; AbA,
Aureobasidin A; P4, D-threo-1-phenyl-2-palmitoyl-3-pyrrolidinopropanol.
revealed the importance of these sphingolipids in normal fungal
morphogenesis and infectivity. In the last 25 years our lab has
made efforts to isolate and analyze the structure of more than
20 new fungal GSLs. In this review we focus on glycan structures
carried on sphingolipids of pathogenic/opportunistic fungi and
multiple aspects of their biological significance.
STRUCTURAL ELUCIDATION OF GSLs ISOLATED FROM
PATHOGENIC FUNGI
Our laboratory and other research groups have characterized
a number of neutral GSLs, glucosyl- and galactosylceramide
(GlcCer and GalCer), as well as acidic GSLs—the glycosylinositol-
phosphorylceramides (GIPCs) from pathogenic/opportunistic
fungi, using a combination of high performance thin layer chro-
matography (HPTLC), gas chromatography/mass spectrometry
(GC/MS), single quadrupole mass spectrometry, 1H/13C nuclear
magnetic resonance—Correlation Spectroscopy (COSY), Total
Correlation Spectroscopy (TOCSY), Nuclear Overhauser Effect
Spectroscopy (NOESY) as well as other immunochemical and
biochemical techniques.
As shown in Figure 2 contrasting to mammalian monohex-
osilceramides, fungal GlcCer and GalCer displays interesting
structural peculiarities in their ceramide moiety, such as the pres-
ence of (E)-8-unsaturation and a methyl group linked to sph-
ingosine, i.e., (4E,8E)-9-methyl-4,8-sphingadienine as long chain
FIGURE 2 | A typical glucosylceramide from fungi. Differently from
mammalian GlcCer, fungal GlcCer displays structural peculiarities in their
ceramide, such as presence of (E)-8-unsaturation and a methyl group
linked to sphingosine (highlighted by red box). Another feature that is
particular to fungal GlcCer is the (E)-3-unsaturation and the presence of a
hydroxyl group linked to C2 of the fatty acid moiety (highlighted by green
box) (Toledo et al., 1999).
base (d19:2), In Cryptococcus neoformans, the methylation in C9
on the sphingosine backbone of GlcCer is associated with fungi
virulence, since the mutation of the sphingolipid C9 methyl-
transferase gene (SMT1), resulted in loss of more than 80%
of its virulence, when compared to the wild-type and/or the
reconstituted strains (Singh et al., 2012).
Another feature that is particular to fungal GlcCer/GalCer
is the (E)-3-unsaturation and the presence of a hydroxyl
group linked to C2 of the fatty acid moiety, having either
N-2′-hydroxyoctadecanoate (h18:0) or the unsaturated form
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N-2′-hydroxy-(E)-3′-octadecenoate (h18:1) [(E)-13-unsaturated
fatty acid] (Takahashi et al., 2009). GlcCer from mycelium
forms of Paracoccidioides brasiliensis and Histoplasma capsulatum
present a higher percentage of unsaturated fatty acids, indicat-
ing that the temperature change which induces the transition of
mycelium to yeast forms possibly activates a fatty acid desaturase
(Toledo et al., 1999, 2001).
Additionally, for yeast forms of Sporothrix schenckii it was
observed that the expression of both GlcCer and GalCer was
approximately equimolar, while mycelial forms displayed only
GlcCer. These differences in neutral GSLs expression suggest that
the activation of GalCer synthase may accompanies the mycelium
to yeast transition, or, conversely, the suppression of this activity
may accompany the yeast to mycelium transition in this fungus
(Toledo et al., 2000). Concurrently in two non-dimorphic fungi
Aspergillus fumigatus and Aspergillus niger, it was reported the
expression of both GlcCer and GalCer, with GalCer bearing a high
percentage of unsaturated fatty acid when compared to GlcCer
(Villas Boas et al., 1994; Toledo et al., 1999; Levery et al., 2000).
On the other hand, inositol phosphorylceramides (IPCs)
and their glycosylated derivatives (GIPCs) are widely dis-
tributed among fungal species of the two phyla Ascomycota
and Basidiomycota. Fungal GIPCs, display a significant glyco-
syl structural variation (Barr and Lester, 1984; Barr et al., 1984;
Levery et al., 1996, 1998; Loureiro y Penha et al., 2001; Toledo
et al., 2007; Suzuki et al., 2008). The glycan structures of fun-
gal GIPCs are built-up on three different “cores”: (i) GlcNα1-
2Ins; (ii)Manα1-6Ins; and (iii) Manα1-2Ins. The glycosylation
of IPCs seems to occur upon a ceramide mainly composed by
t18:0 4-hydroxysphinganine (phytosphingosine) and h24:0 fatty
acid (Takahashi et al., 2009). It is worth mentioning that the
lipid moiety of these GIPCs when compared to glucosyl- and
galactosylceramide displayed different sphingosines, with 4,8-
diene-9-methyl-sphingo base as precursor for GlcCer/GalCer
synthesis, and phytosphingosine for IPC synthesis, suggesting a
dichotomy in the biosynthetic pathway of fungal neutral and
acidic GSLs (Leipelt et al., 2001). The expression of GIPCs in
fungi is summarized in Figure 3.
From an evolutionary perspective, an analysis of GSLs in
basal lineages of fungi, such as zygomycetes (James et al., 2006;
McLaughlin et al., 2009), revealed that this phylum expresses only
neutral GSLs, no inositol-containing sphingolipids were detected
(Aoki et al., 2004), differently from higher fungi representatives
such as Ascomycota and Basidiomycota where both neutral GSLs
and GIPCs are expressed.
Thus, considering the structural diversity of fungal GSLs, stud-
ies aiming to investigate the structure-function relationship of
these glycoconjugates and their phylogenetic distribution in fungi
kingdom may open new perspectives allowing to identify specific
targets for new generation of antifungal drugs.
INHIBITION OF GSL BIOSYNTHETIC PATHWAYS AS
TARGETS FOR NEW ANTIFUNGAL THERAPIES
Hence, in order to better understand the importance/biological
role of GSLs in different fungi, combined with studies searching
for new alternatives for antifungal therapies, a series of stud-
ies were conducted in our laboratory to analyze the inhibition
effect of key enzymes involved in biosynthetic pathways of fungal
GlcCer and GIPCs.
Studies performed with inhibitors of GlcCer synthase,
D-threo-1-phenyl-2-palmitoyl-3-pyrrolidinopropanol (P4) and
D-threo-3P,4P-ethylenedioxy-P4 (EDO-P4), showed a strong
inhibition of germination and hyphal growth, affecting also fun-
gal colony formation of A. fumigatus and A. nidulans (Levery
et al., 2002). Similar results were observed when P. brasiliensis,
H. capsulatum, S. schenckii, and C. neoformans were cultivated in
the presence of P4 (Takahashi et al., 2009). It is worth mentioning
that antimicrobial peptides, such as the plant defensin RsAFP2,
also display antifungal activity against Candida isolates by inter-
action with fungal GlcCer (Tavares et al., 2008; Thevissen et al.,
2012; Silva et al., 2014). Further improvement of existing GlcCer
synthase inhibitors, based on the active site of the fungal enzyme
may confer higher selectivity for these compounds, a key step for a
more efficient therapy of fungal infections, with fewer side effects
on the patients.
Other approaches may also lead to interesting results in studies
regarding GlcCer and its influence in host/pathogen interactions,
which consists in the use of GlcCer-deficient mutants (gcs1) of
pathogenic fungi. As shown by Rittershaus et al. (2006) C. neofor-
mansmutant strain lacking GlcCer was unable to grow in vitro at
a neutral/alkaline pH in the presence of 5% CO2, a condition that
mimics the host extracellular environment, such as in alveolar
spaces or in the bloodstream. However, growth of these mutants
was similar to wild type at acidic pH, which mimics the host
intracellular environment, such as macrophage-phagolysosome.
Furthermore, when these GlcCer defective mutants were incu-
bated with J774.16 macrophage-like cells, no differences in intra-
cellular growth of mutant cells were observed in comparison to
the wild-type, suggesting that GlcCer does not have a relevant
role in C. neoformans intracellular development. Considering the
fact that in Cryptococcus infections they are predominantly in the
extracellular environment, GlcCermay represent a highly relevant
molecule associated with virulence of C. neoformans.
In the last few years, RNAi technology has been used in
silencing genes in Saccharomyces spp and Candida albicans yeasts
(Drinnenberg et al., 2009; Moazeni et al., 2012). Also, some spe-
cific features of fungal GlcCer may represent potential targets for
therapy, e.g., methylation at C9 and desaturation at C8 of sph-
ingosine, hydroxylation at C2 and desaturation at C3 of the fatty
glucosylceramide synthase (GCS) as well as other enzymes related
to this biosynthetic pathway could be reduced. As pointed out in
a recent review by Del Poeta et al. (2014) GlcCer may be consid-
ered a key molecule in fungal infectivity, therefore, this approach
may help to develop new therapeutic strategies based on silencing
specific target sequences not present in mammals.
Concerning the other biosynthetic route of GSLs in fungi, the
IPC and GIPCs synthesis, the first step is catalyzed by the trans-
fer of a phosphoinositol group from a phosphatidylinositol to a
ceramide (or phytoceramide) (Nagiec et al., 1997), which also
represents potential target for the development of new antifun-
gal drugs. In cultures of Saccharomyces cerevisiae, the inhibition
of IPC synthase by Aureobasidin A (AbA), a highly specific phar-
macological inhibitor of IPC synthase (Takesako et al., 1993)
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FIGURE 3 | Acidic glycosphingolipids found in fungi according to fungal
phylogenetic relationships. The scheme shows two sub-phylum from the
Phylum Ascomycota: sub-phylum Saccharomycotina and sub-phylum
Pezizomycotina. The former is represented by two of the most studies yeast,
Candida spp and S. cerevisiae, their GIPCs were described by Steiner
(Steiner et al., 1969), as two basic structures (Man2IPC and IP6Man2IPC).
Five fungi are representing the sub-phylum Pezizomycotina, as can be
observed they present the most variable repertoire of glycan structures in
three possible core: Manα2IPC, which is present in all five fungi; GlcNα2IPC,
which is present in A. fumigatus and S. schenckii; and Manα6IPC which is
present only in S. schenckii (Barr and Lester, 1984; Barr et al., 1984; Toledo
et al., 1995, 2000, 2007; Levery et al., 1996, 1998; Loureiro y Penha et al.,
2001; Aoki et al., 2004; Suzuki et al., 2008). Phylum Basidiomycota is
represented by C. neoformans which presents GIPCs with up to eight
residues of carbohydrates expressing xylose residues. It is noteworthy that
its capsule is rich in xylose (Heise et al., 2002).
(Figure 1), led to the abnormal budding and fungal death (Endo
et al., 1997). Takesako et al. (1993) also showed that AbA oral
treatment in mice with systemic candidiasis was effective and
showed low toxicity for the host. In a more recent experimen-
tal approach Tan and Tay (2013) tested the in vitro susceptibility
of 92 clinical isolates of various Candida species to AbA. These
authors described that planktonic Candida yeasts were more sus-
ceptible to AbA than Candida forms present in biofilm (MIC50 of
1.0 vs. 8.0μg.mL−1, respectively). In this study it was also demon-
strated that AbA inhibited filamentation and lead to short hyphae
formation which may have disabled the biofilm development
by C. albicans, though biofilm formation and development is a
highly complex process which still remain to be fully understood
(Shopova et al., 2013; Guimarães and Takahashi, 2014).
Blocking the synthesis of GIPCs with inhibitors also may con-
fer the additional advantage of microbial selectivity considering
the fact that this class of GSL is absent in mammalian cells.
However, fungi that lack GIPC biosynthetic pathway, such as
zygomycetes presented resistance to AbA (Aoki et al., 2004) and
they will probably be resistant to others inhibitors of IPC syn-
thase. Therefore, the use of enzymatic inhibitors for one or both
GSL biosynthetic pathways must vary according to the fungi,
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allowing the combination of both therapies for most efficient
antifungal therapies by blocking GSC and IPC synthase without
affecting the biosynthetic pathways of the host.
FUNGAL GSLs AS MODULATORS OF HOST IMMUNE
RESPONSE
Besides the importance of GSLs for normal fungal develop-
ment, studies performed by our group and other investiga-
tors have shown that some fungi elicit immune responses in
the infected host. More specifically, it was demonstrated that
GIPC Pb-3 (Galf β6[Manα3]Manα2InsPCer) elicited in patients
with paracoccidioidomycosis (PCM) an immune response with
production of antibodies directed to the terminal residue β-D-
galactofuranose. Also, several GIPCs from H. capsulatum and
A. fumigatus bearing a terminal residue of βGalf presented cross-
reactivity with sera of PCM (Barr and Lester, 1984; Toledo
et al., 1995, 2007; Bertini et al., 2007). The primary immune
response of patients with PCM was associated with IgM pro-
duction and further switched to IgG1. IgG1 titers decreased
after 5 months of antifungal therapy with sulfamethoxazole-
trimethoprim accompanied with the decline of the symptoms
(Bertini et al., 2007).
Passive immunization with mouse monoclonal antibody
directed to Cryptococcus GlcCer was reported to prolong sur-
vival of mice infected with C. neoformans (Rodrigues et al., 2007).
Conversely, data from our laboratory using a specific monoclonal
antibody directed to fungal GlcCer did not show any significant
inhibitory effect on P. brasiliensis, H. capsulatum, and S. schenckii
colony formation units and fungal growth rate (Toledo et al.,
2010). Although promising, the effect of anti-GlcCer antibodies
on humans should be carefully assessed in order to fully under-
stand the mechanisms of the modulatory response to anti-GlcCer
antibodies as well as to determine their effectiveness as a therapy
for different mycosis.
Concerning the cellular immune response against GSLs,
experiments were carried out with concanavalin A activated
BALB/c lymphonode cells and showed that purified prepa-
rations of GIPCs from P. brasiliensis (Manα3Manα2IPC and
Galf β6[Manα3]Manα2IPC), A. fumigatus (Manα2Manα3[Galf β
6]Manα2IPC) and S. schenckii (Manα3Manα6GlcNα2IPC), as
well as, GlcCer and GalCer from these three fungi were able to
inhibit T lymphocyte proliferation in vitro in a dose-dependent
manner. It was observed an IC50 ≤ 5μM for GIPCs, whereas an
IC50 of 20μM was observed for GlcCer and GalCer (Takahashi
et al., 2009). Studies performed with GlcCer from A. fumigatus
revealed that this GSL was able to activate in vitro mouse and
human natural killer T cells (iNKT cells), and to induce airway
hyperreactivity in mice (Albacker et al., 2013).
The data above indicate that fungal GSLs, presenting unique
monosaccharide sequences and ceramide moieties may influence
both humoral and cellular responses and potentially may open
new vistas in this field.
FUNGAL GSLs IN MEMBRANE DOMAINS
Recently it was shown by membrane microdomain isolation
protocols that GlcCer and GIPCs are preferentially localized
in these membrane domains. Studies performed by our group
demonstrated that∼40% of ergosterol from membranes of
H. capsulatum is present in membrane microdomain frac-
tions resistant to treatment with non-ionic detergent at 4◦C
(Tagliari et al., 2012). These ergosterol-enriched membrane
microdomains showed a peculiar protein distribution and a
distinct degree of resistance to treatment with methyl-beta-
cyclodextrin (mβCD), a sterol chelator, suggesting the existence
of two populations of membrane microdomains in H. capsula-
tum yeast forms: Type 1, ergosterol-independent microdomains
rich in integrin-like 50 kDa protein and GlcCer and GIPCs,
possibly involved in signal transduction; and Type 2, ergosterol-
dependent microdomains containing Pma1p and the 30 kDa
laminin-binding protein (Figure 4). The type 2 microdomains
were also shown to be important for infectivity of alveolar
macrophage since after the treatment of yeasts forms with mβCD,
the infectivity was reduced by 45%. It is worth mentioning that
infectivity of mβCD-treated yeasts was completely restored by
addition of exogenous ergosterol, but not cholesterol indicating
that specifically ergosterol is able to restore the functionality of
these fungal membrane domains.
In agreement with these findings, Singh et al. (2012) demon-
strated that structural variation in sphingolipids from C. neo-
formans smt1 mutant strain (which lacks sphingolipid C9
methyltransferase activity) altered the topography of the mem-
brane lipid affecting fungal plasma membrane rigidity, which
was associated with a decrease in the fungal pathogenicity. In
the same study, they described that sphingolipid microdomains
in C. neoformans wild type are larger and more tightly packed
than in smt1. Furthermore, these authors also reported extra
“soft areas” in the smt1 mutant cell membranes, which may
lead to a more permeable and more fluid lipid bilayer, resulting
in a less rigid conformation of selected sections of the membrane.
These data also strongly suggest that the methylated forms of
sphingolipids are required for a proper membrane organization
associated with fungal virulence.
The dependence of the GSLs organization in plasma mem-
brane for fungal infectivity was studied a using mAbs directed
to glycan components of fungal membrane microdomains. We
have demonstrated that mAb MEST-3, an IgG2a directed to
Manpα3Manpα2IPC, interfered on colony formation and mor-
phological transition from yeast to mycelium of P. brasilien-
sis, H. capsulatum and S. schenckii. Similar results were also
observed when these fungi where incubated with mAb MEST-
1, which reacts with GIPCs presenting terminal residues of β-
D-galactofuranose linked to mannose. A possible explanation
for these results could be related to the binding of these two
mAbs with cell surface GIPCs thus altering the lipid bilayer
organization and hindering the formation of functional mem-
brane microdomains leading to interference in GSLs dependent
signaling pathways (Toledo et al., 2010).
Membrane microdomains of host cells were also found to be
involved in host cell-pathogen interaction. As demonstrated by
our group (Maza et al., 2008) in experiments performed with
human lung A549 epithelial cells, the membrane rafts of these
cells are involved in adhesion process of P. brasiliensis yeast forms,
promoting activation of Src-family kinases (SFKs) and extra-
cellular signal-regulated kinase 1/2 (ERK1/2) of these epithelial
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FIGURE 4 | Hypothetical model proposed for fungal membrane
microdomains. Two populations of detergent-resistant membrane
microdomains are displayed in fungal plasma membrane: Type-1:
ergosterol-independent microdomain, rich in integrin-like proteins and GSLs,
possibly involved in signal transduction; Type-2: ergosterol-enriched
microdomains containing Pma1p and the 30 kDa laminin-binding protein.
cells. The activation of epithelial cells SFKs or ERK1/2 might be
involved in expression of host inflammatory cytokines and there-
fore P. brasiliensis through its microdomains could be involved in
modulation of host immune responses.
The concept of “glycosynapses” introduced by Hakomori
(2004) helps to understand the nature and complexity of
microdomains/membrane rafts interactions between host-fungal
cells. The glycan moiety of fungal GIPCs and GlcCer/GalCer
acting in a concerted way with carbohydrate sequences of
GSLs/glycoproteins of complementary host cell microdomains
(trans-interaction) may intermediate cell-to-cell adhesion with
concurrent signal transduction.
CONCLUSIONS AND FUTURE PERSPECTIVES
Due to its importance in clinical contexts, fungal infections
have raised questions regarding its biological process and the
key molecules related with the infection maintenance and host
cell-pathogen interaction. Considering the structural diversity
and the biological roles described for fungal GlcCer and GIPCs,
disruption of these biosynthetic pathways may represent an inter-
esting/inviting approach to new vistas for fungal infection ther-
apy. Furthermore, considering the influence of fungal GSLs in
host immune response, they may also be considered as fungal
biomarkers to detect and identify fungal infections, and as well
as follow-up markers of a mycosis at different stages.
Taking these findings together, the next steps would include
the elucidation of the biological role of GSLs in the interac-
tion of host-fungal cells during the course of the infection. As
shown by Maza et al. (2008) and Tagliari et al. (2012) mem-
brane microdomains of both fungi and host cells play important
roles in these interactions, such as observed for fungal adhesion
to epithelial cells and fungal infectivity of alveolar macrophages.
Additionally, other issues regarding the role of fungal cell wall
in the cellular contact must also be elucidated. It is tempting
to hypothesize that around the fungal membrane microdomain
regions, the glycans of the cell wall could be less tight, leading to a
more “coarse” organization, this hypothetical model is tentatively
shown in Figure 4. This more loose conformation of the cell wall
around the microdomain regions could expose these membrane
structures such as: adhesins, glycosphingolipids and glycopro-
teins allowing the cross-talk of pathogen-host cell through the
membrane microdomains.
Cellular membranes are not autonomous cellular structures,
since they are linked to intracellular and extracellular networks
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(Nicolson, 2014). One attractive hypothesis is that fungal cell wall
could act as biological interface or “conduit” for the information
transfer between membrane microdomain and cell wall, perhaps
in a glycan-glycan communication and thus mediating the trans-
mission of signals either on localized points or in a network at the
cell wall modulating biological events in fungal biology as well as
in the fungal infection.
An in-depth knowledge of fungal microdomain interactions in
combination with the elucidation of the GSL glycan-dependent
signaling pathways and cell wall biosynthesis regulatory steps
will certainly provide an integrated view allowing to elab-
orate a more refined concept of the concerted membrane
microdomain-GSL-cell wall involved in key events related to sur-
vival and proliferation of pathogenic/opportunistic fungi in the
human host.
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